News

CanadaBis Capital Reports Q3 Revenue With Positive Adjusted EBITDA

CanadaBis Capital Reports Q3 Revenue With Positive Adjusted EBITDA

CanadaBis Capital's Impressive Q3 Financial Results

CanadaBis Capital, a prominent player in the cannabis industry, has recently released its financial results for the third quarter of its fiscal year. The Company has announced that it achieved a positive adjusted EBITDA of $440,665, showcasing its ability to thrive in a challenging market environment. With gross sales reaching an impressive $5.5 million for this quarter, CanadaBis illustrates its resilience and operational efficiency amidst industry fluctuations.

Financial Highlights of Q3 2025

The financial outcomes from CanadaBis demonstrate significant progress. Notably, the Company recorded a 6% increase in gross earnings when compared to previous periods. Gross revenue for Q3 2025 was reported at $5.5 million, reflecting strategic decisions to streamline product offerings. This shift ensured the removal of underperforming SKUs from provincial boards, a crucial tactic during periods of slower cannabis sales.

Strategic Cost Management

CanadaBis Capital’s CEO emphasized the importance of their team’s dedication and strategic approach. In response to the cost-effective measures implemented, Selling, General and Administrative (SG&A) expenses dropped significantly to $1.4 million, down 30% from $1.8 million in the same period last year. This disciplined approach to cost management played a vital role in sustaining a positive EBITDA.

Product Innovation and Market Demand

One of the standout features of CanadaBis's success in this quarter was the successful launch of their diamond and Keef-coated pre-rolls. This product has reportedly been sold out multiple times during the quarter, indicating strong market demand and consumer interest. The Company is not resting on its laurels as it gears up to launch innovative vape hardware later this year, aiming to re-establish the Stigma Grow brand in the competitive vape market.

Debt Reduction and Financial Health

Further emphasizing its financial prowess, CanadaBis was successful in reducing its short-term debt by $2.5 million this quarter. This initiative highlights the Company’s ongoing commitment to improving its financial health and operational stability. Such measures are critical as CanadaBis seeks opportunities to expand its product offerings and explore international markets.

Liquidity and Strategic Growth

Earlier in the year, CanadaBis completed a brokered private placement that raised gross proceeds of $4,035,000. This financing enhances the Company’s short-term liquidity, positioning it favorably for future strategic growth opportunities. As CanadaBis continues to optimize and control costs, it is now looking into expanding flower sales and licensing its brands internationally, alongside bulk extract sales through domestic business-to-business channels.

Future Outlook and Commitment

With a focus on long-term growth, CanadaBis Capital is dedicated to navigating its strategic management decisions and continuing to implement cost-saving initiatives. The management's confidence in their ability to leverage future opportunities in the rapidly evolving cannabis sector is evident. Their adaptations and responses to market demands not only set the course for recovery but also pave the way for a thriving future.

About CanadaBis Capital Inc.

CanadaBis Capital Inc. (TSXV: CANB) is a fully integrated Canadian cannabis company committed to cultivating high-quality cannabis products while building a trusted portfolio of brands. The Company seeks to deliver enhanced value to shareholders and believes in exploring innovative pathways to growth in the global cannabis market.

Frequently Asked Questions

What is Canada's positive adjusted EBITDA for Q3 2025?

CanadaBis Capital reported a positive adjusted EBITDA of $440,665 for Q3 2025.

How much gross revenue did CanadaBis achieve this quarter?

The Company achieved gross revenue of $5.5 million for the third quarter of fiscal 2025.

What initiatives are being launched to boost CanadaBis's market positioning?

CanadaBis is preparing to launch innovative vape hardware and has successfully launched diamond and Keef-coated pre-rolls.

How has CanadaBis managed to reduce expenses?

The Company successfully decreased Selling, General and Administrative expenses by 30%, leading to improved profit margins.

What are CanadaBis's plans for growth?

CanadaBis is focusing on expanding its product offerings, potential international licensing, and optimizing operations for enhanced efficiency.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 2

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 1

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 1

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 1

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 0

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 2

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 2

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 2

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Opportunities for Capricor Investors Facing Losses

Updated Category News Views 154

Capricor Therapeutics Faces Legal Scrutiny Capricor Therapeutics, Inc. (NASDAQ: CAPR) finds itself at the center of a significant legal issue as investors come forth with claims of securities fraud. The Rosen Law Firm, a leader in investor rights, has highlighted an important opportunity for those who purchased Capricor's securities during a specified period. This legal...

Continue Reading
Revolutionizing Therapeutics: Harbour BioMed’s AI Innovations

Updated Category News Views 221

Revolutionizing Therapeutics with AI Technology Harbour BioMed, a renowned biopharmaceutical leader, has made significant advancements in the field of drug discovery. The company specializes in developing novel antibody therapeutics primarily targeted at immunology and oncology. Their latest innovation arrives with the launch of the first fully human Generative AI HCAb...

Continue Reading
Intuit Surges in Premarket Trading Amid Strong Earnings Report

Updated Category News Views 152

Intuit Inc Sees Promising Growth in Premarket Trading Intuit Inc (NASDAQ: INTU) has experienced a significant rise in its shares during premarket trading sessions, primarily due to its impressive financial performance in the recent quarter. The company's earnings report has exceeded market expectations, showcasing its ability to thrive in a competitive landscape....

Continue Reading
HR Acuity and Labor Relations Institute Forge Dynamic Alliance

Updated Category News Views 235

HR Acuity Announces Innovative Partnership with Labor Relations Institute HR Acuity has joined forces with Labor Relations Institute Consulting Services (LRICS) to foster a new era of collaboration among labor relations professionals. This exciting initiative aims to extend support to the increasingly critical domain of labor relations, particularly as workplace dynamics...

Continue Reading
Subsea7 Excels with New Offshore Development Contract

Updated Category News Views 186

Subsea7 Engages in New Offshore Project In a significant development for Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY), the company has secured a pivotal contract with ConocoPhillips Skandinavia AS for conducting a front-end engineering and design (FEED) study. This contract pertains to the Previously Produced Fields (PPF) project offshore, which marks an exciting stride...

Continue Reading